SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-18-214801
Filing Date
2018-07-09
Accepted
2018-07-09 17:15:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D (AMENDMENT NO. 1) d669726dsc13da.htm SC 13D/A 28273
  Complete submission text file 0001193125-18-214801.txt   29914
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90473 | Film No.: 18945368
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 (908) 947-3120
APHC Holdings, LLC (Filed by) CIK: 0001739290 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A